Showing results (1161-1170 of 1,716) with videos related to
Sort By:
Pageof 172
NPJ Precision Oncology|November 25, 2025
Predicting colorectal cancer survival by combined c-reactive protein and tumor immune scoreTafirenyika Gwenzi, Durgesh Wankhede, Tanwei Yuan, et al.The Journal of Cell Biology|February 16, 2011
Polycystin-2 takes different routes to the somatic and ciliary plasma membraneHelen Hoffmeister, Karin Babinger, Sonja Gürster, et al.Circulation|December 8, 1998
Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasminH M Hoffmeister, S Szabo, C Kastner, et al.Clinical and Experimental Medicine|June 4, 2025
Personalized drug stratification using endoscopic samples to assess ex vivo gastric cancer tissue susceptibility to chemotherapy and immune checkpoint inhibitorsLaura Hennig, Astrid Monecke, Ngoc Anh Hoang, et al.International Journal of Colorectal Disease|May 10, 2025
Drug dissolution problems in ostomy patients: a chart review and patient interview analysisYvonne Remane, Maria Astrid Stolz, Katrin Heinitz, et al.The American Journal of Cardiology|August 3, 2000
Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarctionH M Hoffmeister, C Kastner, S Szabo, et al.Zeitschrift Fur Gastroenterologie|March 13, 2019
Severe ileocecal inflammatory syndrome in adult patients with cystic fibrosisRobert Henker, Annett Oltmanns, Alexandra Wald, et al.IEEE Transactions on Medical Imaging|April 9, 1998
Computer-aided breast cancer detection and diagnosis of masses using difference of Gaussians and derivative-based feature saliencyW E Polakowski, D A Cournoyer, S K Rogers, et al.BMC Cancer|July 7, 2018
Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancerKaja Tikk, Korbinian Weigl, Michael Hoffmeister, et al.Preventive Medicine|March 1, 1996
Reduction of coronary heart disease risk factors in the German cardiovascular prevention studyH Hoffmeister, G B Mensink, H Stolzenberg, et al.Pageof 172